Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sequencing of AsPC-1 cells with CYP3A5 expression modulation

ABSTRACT: Purpose: To understand the transcriptome-wide effect of CYP3A5 knockdown or over-expression in AsPC-1 cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE149000 | GEO | 2024/04/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Sequencing of AsPC-1 cells with CYP3A5 expression modulation

Project description:Sequencing of AsPC-1 cells with CYP3A5 expression modulation

| PRJNA627104 | ENA

Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.

Project description:Purpose: To know the expression of all cytochrome P450 (CYP) enzymes and related drug metabolizing enzymes in pancreatic cancer models Methods: We obtained expression profiles of 8 commercially-available pancreatic cancer cell lines and one non-cancerous immortalized cell line by RNA-sequencing. The pancreatic cancer cells were compared among themselves and to the non-cancerous control cells. Results: We confirmed reports that CYP3A5 is highly overexpressed in pancreatic cancer models, and additionally report that known xenobiotic-metabolizing CYPs are lowly expressed in comparison.

2020-03-01 | GSE138437 | GEO

Transcription profiling on non-small cell lung cancer samples reveals CYP3A5 gene expression is associated with early recurrence

Project description:Study to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Purpose: Recent clinical trials suggest improvement in survival with adjuvant chemotherapy in non-small cell lung cancer (NSCLC). This study's aim is to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Experimental design: Banked NSCLC tumors of patients who underwent resection of stage Ia-IIIb disease were identified. Patients were stratified into two groups: recurrent (R, n=11) or non-recurrent (NR, n=16) 2 years after surgery. Microarray profiling and Cox multivariate analysis were performed. Conclusion: Increased CYP3A5 gene expression correlates with NSCLC recurrence and promotes proliferation through mechanisms that may involve, in part, CYP3A5 epoxygenase activity. Experiment Overall Design: comparison of gene expression profiles for recurrent and non-recurrent cancer

2009-12-14 | E-GEOD-9971 | biostudies-arrayexpress

CYP3A5 Gene Expression is Associated with Early Recurrence of Non-small Cell Lung Cancer

Project description:Study to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Purpose: Recent clinical trials suggest improvement in survival with adjuvant chemotherapy in non-small cell lung cancer (NSCLC). This study's aim is to identify genes associated with NSCLC recurrence in patients not receiving adjuvant chemotherapy. Experimental design: Banked NSCLC tumors of patients who underwent resection of stage Ia-IIIb disease were identified. Patients were stratified into two groups: recurrent (R, n=11) or non-recurrent (NR, n=16) 2 years after surgery. Microarray profiling and Cox multivariate analysis were performed. Conclusion: Increased CYP3A5 gene expression correlates with NSCLC recurrence and promotes proliferation through mechanisms that may involve, in part, CYP3A5 epoxygenase activity. Keywords: comparison of gene expression profiles for recurrent and non-recurrent cancer

2009-12-01 | GSE9971 | GEO

MiRNA microarray of overexpression Ctrl and PRLR AsPC-1 cells.

Project description:The study is to explore differentially expressed miRNAs in AsPC-1 cells overexpressing Ctrl or PRLR.

2022-10-14 | GSE215273 | GEO

Gene expression from AsPC-1 cells treated with PTC596 and DMSO

Project description:This study examines the transcriptional changes invoked by the novel anti-cancer agent PTC596 in AsPC-1 pancreatic cancer cells as compared to DMSO.

2019-06-11 | GSE118441 | GEO

Genome-wide expression analysis of overexpressing Ctrl and PRLR-SF AsPC-1 cells

Project description:The study is to explore differentially expressed genes in AsPC-1 cells overexpressing Ctrl or PRLR-SF.

2020-10-24 | GSE159917 | GEO

Homo sapiens strain:AsPC-1

Project description:Homo sapiens strain:AsPC-1 Raw sequence reads

| PRJNA431926 | ENA

RNA-Seq identification of LGK974 early and late gene targets in AsPC-1

Project description:RNA sequencing with differential gene expression analysis was performed on AsPC-1 pancreatic ductal adenocarcinoma (PDAC) cells at multiple time points with a Porcupine inhibitor (LGK974) to identify mechanisms underpinning transcriptional effects.

2022-04-19 | GSE180615 | GEO

VU-0365114-treated AsPC-1 and PANC-1

Project description:VU-0365114-treated AsPC-1 and PANC-1

| PRJNA705877 | ENA